ECSP099536A - Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas - Google Patents

Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas

Info

Publication number
ECSP099536A
ECSP099536A EC2009009536A ECSP099536A ECSP099536A EC SP099536 A ECSP099536 A EC SP099536A EC 2009009536 A EC2009009536 A EC 2009009536A EC SP099536 A ECSP099536 A EC SP099536A EC SP099536 A ECSP099536 A EC SP099536A
Authority
EC
Ecuador
Prior art keywords
antiprogestines
formulations
methods
improved
biodisponibility
Prior art date
Application number
EC2009009536A
Other languages
English (en)
Inventor
Joseph Podolski
Original Assignee
Repros Therapeutis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutis Inc filed Critical Repros Therapeutis Inc
Publication of ECSP099536A publication Critical patent/ECSP099536A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere en términos generales a composiciones con biodisponibilidad mejorada que comprenden por lo menos una antiprogestina. Más particularmente, la invención presente se relaciona con una potente actividad antiporgestacional, actividad antiglucocorticoide mínima y biodisponibilidad mejorada, comprendiendo un derivado de 19-norprogesterona I y opcionalmente un excipiente farmacéuticamente aceptable.
EC2009009536A 2006-12-28 2009-07-23 Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas ECSP099536A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88242306P 2006-12-28 2006-12-28
US88537207P 2007-01-17 2007-01-17

Publications (1)

Publication Number Publication Date
ECSP099536A true ECSP099536A (es) 2009-08-28

Family

ID=39589194

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009536A ECSP099536A (es) 2006-12-28 2009-07-23 Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas

Country Status (14)

Country Link
EP (1) EP2094275A2 (es)
JP (1) JP2010514793A (es)
KR (1) KR20090086470A (es)
AR (1) AR064697A1 (es)
AU (1) AU2007339820A1 (es)
CA (1) CA2672888A1 (es)
CL (1) CL2007003855A1 (es)
CO (1) CO6190605A2 (es)
EA (1) EA200970646A1 (es)
EC (1) ECSP099536A (es)
MX (1) MX2009006912A (es)
NO (1) NO20092271L (es)
TW (1) TW200831110A (es)
WO (1) WO2008083192A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299050B2 (en) 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
ME02548B (me) 2009-04-14 2017-02-20 Hra Pharma Lab Postupak za kontracepciju po potrebi
EP2471537A1 (en) * 2010-12-30 2012-07-04 PregLem S.A. Treatment of pain associated with dislocation of basal endometrium
EP2545922A1 (en) 2011-07-12 2013-01-16 PregLem S.A. Treatment of excessive menstrual bleeding associated with uterine fibroids
WO2013059664A1 (en) * 2011-10-21 2013-04-25 Seachaid Pharmaceuticals, Inc. Pharmaceutical compositions and uses thereof
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
FR2997628B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
FR2999081B1 (fr) * 2012-12-06 2015-02-27 Hra Pharma Lab Dispersion solide d'un modulateur selectif du recepteur a la progesterone
SG11201507260QA (en) 2013-04-10 2015-10-29 Preglem Sa Progesteron receptor modulators for use in the therapy of uterine fibroids
WO2018106914A1 (en) * 2016-12-09 2018-06-14 Repros Therapeutics Inc. Oral pharmaceutical compositions comprising an unmicronized selective progesterone receptor as active agent
WO2017216637A2 (en) 2017-08-04 2017-12-21 Alvogen Malta Operations (Row) Ltd Tablet form including ulipristal acetate and the methods for its preparation
WO2023033900A1 (en) 2021-09-06 2023-03-09 Slayback Pharma Llc Pharmaceutical compositions of mifepristone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2668824A1 (en) * 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secre Tary Of The Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2821555B1 (fr) * 2001-03-01 2003-05-16 Besins Int Lab Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
CA2623678A1 (en) * 2005-09-29 2007-04-05 Repros Therapeutics Inc. Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride

Also Published As

Publication number Publication date
TW200831110A (en) 2008-08-01
WO2008083192A8 (en) 2009-07-09
AU2007339820A1 (en) 2008-07-10
NO20092271L (no) 2009-08-06
WO2008083192A2 (en) 2008-07-10
EP2094275A2 (en) 2009-09-02
EA200970646A1 (ru) 2009-12-30
KR20090086470A (ko) 2009-08-12
JP2010514793A (ja) 2010-05-06
CL2007003855A1 (es) 2008-03-14
CA2672888A1 (en) 2008-07-10
AR064697A1 (es) 2009-04-22
CO6190605A2 (es) 2010-08-19
MX2009006912A (es) 2009-08-12
WO2008083192A3 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
ECSP099536A (es) Métodos y formulaciones para biodisponibilidad mejorada de antiprogestinas
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
IL247485A0 (en) Estrogen preparations for vaginal administration
BRPI0509184A (pt) composições farmacêuticas
IL192948A0 (en) Novel pyridine derivatives
MY154909A (en) Novel thiophene derivatives
IL184394A0 (en) Bendamustine pharmaceutical compositions for lyophilisation
EP2344198A4 (en) LIPID (S) PHARMACEUTICAL PREPARATIONS FOR ORAL AND TOPICAL USE, COMPOSITIONS THEREOF, METHODS AND USES
TW200716591A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
MX2007003342A (es) Compuestos para inflamacion y usos relacionados con trastornos inmunitarios.
WO2005067893A3 (en) Pharmaceutical compositions comprising midazolam in a high concentration
IL188043A0 (en) Estrogen compositions for vaginal administration
WO2006138735A3 (en) Gel compositions for topical administration
WO2008073448A3 (en) Pharmaceutical formulations and methods for making the same
WO2008094910A3 (en) Hyaluronate compositions
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
WO2008103847A3 (en) Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
ZA200705793B (en) Bendamustine pharmaceutical compositions for lyophilisation
ZA201004654B (en) Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
CL2009000281A1 (es) Compuestos derivados de 5,6-dihidro-pirrolo-[2,1-a]-isoquinolinas y pirrolo-[2,1-a]-isoquinolinas; composicion farmaceutica que comprende a dichos compuestos; y uso para el tratamaiento de trastornos de la fertilidad.
ATE531721T1 (de) Cyanoaminochinolone als gsk-3-inhibitoren
UA95253C2 (ru) Соединения аналога камптотецина, способ их получения и фармацевтическая композиция, которая их содержит
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same